Abstract
DIALECT aims to combat diabetic foot disease through personalised medicine, by establishing an innovative, international, interdisciplinary and intersectoral research and training effort that will deliver the next generation of leading, entrepreneurial and creative scientists to reinforce the European innovative workforce. This is both timely and urgent, illustrated by that the burden of diabetic foot disease is in the top-10 of all medical conditions, and emphasized by the fact that every 20 seconds someone in the world loses a leg because of foot disease. Currently, we lack success in delivering the right treatment to the right person at the right time to prevent foot ulceration and amputation. We will provide unique world-class interdisciplinary and intersectoral training to a new generation of high-achieving ESRs in the areas of biomechanics, activity behaviour and footwear related to diabetic foot disease. A well-balanced consortium of academic, industry, healthcare and implementation partners will deliver the carefully designed DIALECT training network, comprising training through research, structured network-wide training events, intersectoral secondments and future work skills training. This will result in a paradigm shift towards personalised medicine that goes beyond state-of-the-art, by developing new personalised risk stratifications, biomechanical foot models, innovative activity and adherence profiles, wearable technology systems for biomechanical and activity monitoring, and personalised optimised footwear intervention products. DIALECT will provide ESRs with a comprehensive skillset capable of delivering high-quality scientific and industry solutions to develop into leading innovators in the European healthcare sector, who are highly employable and ready to engage and lead the next European generation of scientistsentrepreneurs to expedite progress in reducing the patient, societal and economic burden of diabetic foot disease.
Project details
Unibo Team Leader: Lisa Berti
Unibo involved Department/s:
Dipartimento di Scienze Biomediche e Neuromotorie
Coordinator:
Academisch Medisch Centrum Bij De Universiteit Van Amsterdam (Amc)(Netherlands)
Other Participants:
ALMA MATER STUDIORUM - Università di Bologna
(Italy)
Total Eu Contribution: Euro (EUR) 2.738.724,78
Project Duration in months: 48
Start Date:
01/10/2022
End Date:
30/09/2026
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101073533